Quick Answer
Coherus Oncology, Inc. reported Earnings Per Share Diluted of $1.43 per share for the year ending 2025.
- Coherus Oncology, Inc. showed an increase of +472.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Coherus Oncology, Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), Coherus Oncology, Inc.'s Earnings Per Share Diluted has grown by 131.9%.
- Historical annual values: Fiscal year 2025: $1.43 per share | Fiscal year 2024: $0.25 per share | Fiscal year 2023: $2.53 (loss) per share | Fiscal year 2022: $3.76 (loss) per share | Fiscal year 2021: $3.81 (loss) per share | Fiscal year 2020: $1.62 per share | Fiscal year 2019: $1.23 per share | Fiscal year 2018: $3.22 (loss) per share | Fiscal year 2017: $4.48 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: